Q1 2025 Holdings
Filed 2025-05-15 | 37 holdings | $411.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Becton Dickinson & Co(BDX) | COM | 075887109 | $46.7M | 203,965 | 11.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $33.5M | 758,533 | 8.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $33.3M | 962,883 | 8.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $31.6M | 435,588 | 7.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $30.5M | 195,523 | 7.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $23.5M | 585,812 | 5.7% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $22.6M | 762,225 | 5.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $21.3M | 1,733,701 | 5.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $19.6M | 23,682 | 4.8% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $18.1M | 36,499 | 4.4% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $15.0M | 381,648 | 3.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $13.8M | 763,471 | 3.4% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $13.7M | 85,877 | 3.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $12.2M | 704,864 | 3.0% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $11.5M | 160,962 | 2.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $8.8M | 830,325 | 2.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.8M | 12,261 | 1.9% |
| Soleno Therapeutics IncCall | CALL | 834203909 | $6.5M | 100,000 | 1.6% |
| Septerna Inc(SEPN) | COM | 81734D104 | $5.9M | 1,024,245 | 1.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $4.6M | 1,088,691 | 1.1% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $4.5M | 611,639 | 1.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.5M | 114,616 | 1.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $4.0M | 389,384 | 1.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $4.0M | 611,608 | 1.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $3.5M | 355,640 | 0.8% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $2.3M | 295,148 | 0.6% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $1.8M | 166,666 | 0.4% |
| Arcutis Biotherapeutics IncPut | PUT | 03969K958 | $1.3M | 100,000 | 0.3% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $1.1M | 586,909 | 0.3% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $719.4K | 528,993 | 0.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $586.9K | 1,705,036 | 0.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $582.2K | 202,139 | 0.1% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $582.0K | 155,622 | 0.1% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $544.4K | 760,035 | 0.1% |
| Atai Life Sciences NV | SHS | N0731H103 | $267.7K | 196,858 | 0.1% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $254.9K | 214,236 | 0.1% |
| Sensei Biotherapeutics Inc | COM | 81728A108 | $116.0K | 294,374 | 0.0% |